Article

Sulfatase 2 Inhibition Sensitizes Triple-Negative Breast Cancer Cells to Chemotherapy Through Augmentation of Extracellular ATP

2023-09-17

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Breast cancer is the leading cause of cancer-related death among women worldwide. Patients diagnosed with triple-negative breast cancer (TNBC) have limited therapeutic options that produce durable responses. Hence, a diagnosis of TNBC is associated with a poor prognosis compared to other types of breast cancer. As a result, there is a critical need for novel therapies that c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9d77c627-05f7-558a-ae38-9b2211d10d3f
DOI: 10.1101/2023.09.15.557965

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Sulfatase 2 Inhibition Sensitizes Triple-Negative Breast Cancer Cells to Chemotherapy Through Augmentation of Extracellular ATPDOI 10.1101/2023.09.15.557965Read

Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells.Semantic proximity Read

Translational drugs targeting cancer stem cells in triple-negative breast cancerSemantic proximity Read

Leveraging Synergy: The Therapeutic Potential of SN-38 and Immunotherapy in Breast and Prostate Cancer TreatmentSemantic proximity Read

Breast Cancer MCF-7 Cell Spheroid Culture for Drug Discovery and DevelopmentSemantic proximity Read

2-Deoxy-D-Glucose inhibits aggressive triple-negative breast cancer cells by targeting glycolysis and the cancer stem cell phenotypeSemantic proximity Read

Huaier Polysaccharides Targets Cancer Stem Cells in Triple-Negative Breast Cancer via ASM-mediated Autophagy-dependent FerroptosisSemantic proximity Read

Extracellular ATP promotes breast cancer invasion and chemoresistance via SOX9 signalingSemantic proximity Read

Fibronectin, DHPS and SLC3A2 Signaling Cooperate to Control Tumor Spheroid Growth, Subcellular eIF5A1/2 Distribution and CDK4/6 Inhibitor ResistanceSemantic proximity Read

Targeting STAT3 signalling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancerSemantic proximity Read

Real-World Outcomes of Subcutaneous PHESGO® in HER2-Positive Breast Cancer: Pathological Response, Se-Quencing, and SafetySemantic proximity Read

High-throughput screen identifies disulfiram as a potential therapeutic for triple-negative breast cancer cells: Interaction with IQ motif-containing factorsSemantic proximity Read

ADT-OH exhibits anti-metastatic activity on triple-negative breast cancer by combinatorial targeting of autophagy and mitochondrial fissionSemantic proximity Read